These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 35387932)
1. [Plasmablastic myeloma initially presented with ascites]. Sato S; Tsunoda S; Kamata W; Tamai Y Rinsho Ketsueki; 2022; 63(3):194-200. PubMed ID: 35387932 [TBL] [Abstract][Full Text] [Related]
2. Plasmablastic morphology is an independent predictor of poor survival after autologous stem-cell transplantation for multiple myeloma. Rajkumar SV; Fonseca R; Lacy MQ; Witzig TE; Therneau TM; Kyle RA; Litzow MR; Gertz MA; Greipp PR J Clin Oncol; 1999 May; 17(5):1551-7. PubMed ID: 10334543 [TBL] [Abstract][Full Text] [Related]
3. [Plasmablastic lymphoma presenting clinical symptoms similar to plasmablastic myeloma]. Nakaya A; Nagate Y; Toda J; Yamashita Y; Hirose Y; Mori K; Shibayama H Rinsho Ketsueki; 2023; 64(4):260-264. PubMed ID: 37121769 [TBL] [Abstract][Full Text] [Related]
4. Plasmablastic myeloma in Taiwan frequently presents with extramedullary and extranodal mass mimicking plasmablastic lymphoma. Chen BJ; Yuan CT; Yang CF; Ho CH; Lin YK; Su YZ; Chou HC; Chuang SS Virchows Arch; 2022 Aug; 481(2):283-293. PubMed ID: 35657404 [TBL] [Abstract][Full Text] [Related]
5. Plasmablastic lymphoma with unfavorable chromosomal abnormalities related to plasma cell myeloma: A borderline case between plasmablastic lymphoma and plasmablastic plasma cell myeloma. Aoyama Y; Tsunemine H; Kodaka T; Oda N; Matsuoka H; Itoh T; Takahashi T J Clin Exp Hematop; 2017; 57(1):37-39. PubMed ID: 28679965 [No Abstract] [Full Text] [Related]
7. Cutaneous localization of plasmablastic multiple myeloma with heterotopic expression of CD3 and CD4: Skin involvement revealing systemic disease. Varricchio S; Pagliuca F; Travaglino A; Gallo L; Villa MR; Mascolo M J Cutan Pathol; 2019 Aug; 46(8):619-622. PubMed ID: 31025408 [TBL] [Abstract][Full Text] [Related]
8. Multiple myeloma presenting initially as a solitary pleural effusion later complicated by malignant plasmacytic ascites. Inoue Y; Chua K; McClure RF; Jimenez MC; Gocke CD; Badros AZ; Takebe N Leuk Res; 2005 Jun; 29(6):715-8. PubMed ID: 15863214 [TBL] [Abstract][Full Text] [Related]
9. Remission induction with lenalidomide alone in a patient with previously untreated plasmablastic myeloma: a case report. Sher T; Miller KC; Lee K; Chanan-Khan A Clin Lymphoma Myeloma; 2009 Aug; 9(4):328-30. PubMed ID: 19717386 [TBL] [Abstract][Full Text] [Related]
10. Genetic Basis of Extramedullary Plasmablastic Transformation of Multiple Myeloma. Liu Y; Jelloul F; Zhang Y; Bhavsar T; Ho C; Rao M; Lewis NE; Cimera R; Baik J; Sigler A; Sen F; Yabe M; Roshal M; Landgren O; Dogan A; Xiao W Am J Surg Pathol; 2020 Jun; 44(6):838-848. PubMed ID: 32118627 [TBL] [Abstract][Full Text] [Related]
11. Multiple myeloma presenting as massive ascites. Alacacioglu L; Turgut N; Piskin O; Ali Ozcan M; Hayri Ozsan G; Demirkan F; Undar B J BUON; 2009; 14(2):307-8. PubMed ID: 19650183 [TBL] [Abstract][Full Text] [Related]
12. Myeloma of the central nervous system: association with high-risk chromosomal abnormalities, plasmablastic morphology and extramedullary manifestations. Fassas AB; Muwalla F; Berryman T; Benramdane R; Joseph L; Anaissie E; Sethi R; Desikan R; Siegel D; Badros A; Toor A; Zangari M; Morris C; Angtuaco E; Mathew S; Wilson C; Hough A; Harik S; Barlogie B; Tricot G Br J Haematol; 2002 Apr; 117(1):103-8. PubMed ID: 11918539 [TBL] [Abstract][Full Text] [Related]
13. Myelomatous pleural effusion in a patient with plasmablastic myeloma: a case report. Chang H; Chou WC; Lee SY; Huang JY; Hung YH Diagn Cytopathol; 2009 Mar; 37(3):205-7. PubMed ID: 19170175 [TBL] [Abstract][Full Text] [Related]
14. Extramedullary progression of multiple myeloma despite concomitant medullary response to multiple combination therapies and autologous transplant: a case report. Kumar AK; Dakhil C; Teeka Satyan M; Haideri N J Med Case Rep; 2014 Sep; 8():299. PubMed ID: 25200389 [TBL] [Abstract][Full Text] [Related]
15. Myelomatous pleural effusion developing after autologous stem cell transplantation in a patient with multiple myeloma: A rare case. Müzeyyen Aslaner A; Barut F Indian J Pathol Microbiol; 2023; 66(4):859-861. PubMed ID: 38084549 [TBL] [Abstract][Full Text] [Related]
16. Myelomatous pleural effusion with plasmablastic morphology and high genetic complexity as isolated extramedullary relapse. Martín-Moro F; Roncancio A; Benito A; Talavera M; Villarrubia J; Blanchard MJ Ann Hematol; 2020 Nov; 99(11):2705-2706. PubMed ID: 32458065 [No Abstract] [Full Text] [Related]
17. Refractory plasmablastic type myeloma with multiple extramedullary plasmacytomas and massive myelomatous effusion: remarkable response with a combination of thalidomide and dexamethasone. Nakazato T; Suzuki K; Mihara A; Sanada Y; Kakimoto T Intern Med; 2009; 48(20):1827-32. PubMed ID: 19834276 [TBL] [Abstract][Full Text] [Related]
18. Solitary bone plasmacytoma terminally developed myeloma with multiple extramedullary lesions and myelomatous pleural effusion and ascites. Matsumoto A; Nagata K; Hamaguchi H; Taki K Int J Hematol; 1993 Dec; 59(1):59-65. PubMed ID: 8161736 [TBL] [Abstract][Full Text] [Related]
19. Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Colomo L; Loong F; Rives S; Pittaluga S; Martínez A; López-Guillermo A; Ojanguren J; Romagosa V; Jaffe ES; Campo E Am J Surg Pathol; 2004 Jun; 28(6):736-47. PubMed ID: 15166665 [TBL] [Abstract][Full Text] [Related]
20. Bone marrow infiltration by plasmablastic neoplasm: plasmablastic myeloma or plasmablastic lymphoma? Eladl E; Chang H Blood; 2021 Mar; 137(9):1268. PubMed ID: 33661296 [No Abstract] [Full Text] [Related] [Next] [New Search]